Authorities in Abu Dhabi have warned the public against using certain brands of cough syrups, manufactured in India, after they have been linked to child deaths in Gambia.
Taking to their official social media handles, the Department of Health — Abu Dhabi (DoH) confirmed that the four products by New Delhi-based Maiden Pharmaceuticals Limited were not sold anywhere in the UAE but warned the public, who may have obtained the products, not to use them.
They "contain contaminated ingredients, according to the World Health Organisation (WHO)", the authority added.
In the eventuality it was consumed, the public have been advised to seek medical help if they show any "side-effects".
The Department of Health — Abu Dhabi (DoH) has confirmed that these four products by Maiden Pharmaceuticals Limited are not available across all healthcare sector in the Emirate as they contain contaminated ingredients, according to the World Health Organization (WHO). pic.twitter.com/wBLNlBQRSU
— دائرة الصحة - أبوظبي (@DoHSocial) October 14, 2022
It comes after India said it's "seriously investigating" the deaths of 70 children in Gambia in the wake of a report that provisionally linked the fatalities to the cough syrups.
UAE fines 42 domestic worker recruitment firms for violating rules
Dubai's RTA expands e-bike delivery service to seven new areas
Sharjah Charity sends food aid to Bangladesh flood victims
UAE condemns Israeli settler attacks in occupied West Bank
President commends global humanitarian efforts of UAE Search and Rescue Team
UAE discusses regional developments with Qatar, Oman
Dubai Police launch doorstep service for lost-and-found items
UAE expresses solidarity with France over wildfires
